Schizophrenia Sensory Gating Deficit With Quetiapine
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is the use of magnetoencephalography or MEG (a machine that
measures magnetic activity in your brain) and electroencephalography or EEG (a technique that
measures electrical activity in your brain) to study how sounds are processed in individuals
with schizophrenia after three months of taking the antipsychotic medication quetiapine.